During the past decade, Leonard van den Berg conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Leonard van den Berg" are "Amyotrophic Lateral Sclerosis" (2 trials). Many other conditions were trialed in "Leonard van den Berg" in a lesser frequency.

Most popular intervention types in "Leonard van den Berg" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "sNN0029" (1 trials) and "sNN0029 infusion solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "Leonard van den Berg" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Leonard van den Berg". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Leonard van den Berg, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Leonard van den Berg, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".